Table 1 Clinical characteristics of AMI patients and the control subjects
Variable | AMI group (n = 31) | Control group (n = 27) | p-value |
|---|---|---|---|
Male/Female (n/n)1 | 25/6 | 19/8 | 0.362 |
Age (years)2 | 61.1 ± 10.0 | 60.1 ± 12.2 | 0.379 |
BMI (kg/m2)2 | 25.5 ± 2.1 | 24.8 ± 4.1 | 0.368 |
Smoking status | |||
 Current smoker (%)1 | 58.1% | 44.4% | 0.188 |
 Former smoker (%)1 | 9.7% | 0 | 0.370 |
 Never (%)1 | 32.2% | 55.6% | 0.074 |
Hypertension (%)1 | 71.0% | 22.2% | < 0.001** |
Diabetes (%)1 | 32.3% | 11.1% | 0.054 |
SBP (mmHg)3 | 129.4 ± 22.0 | 124.6 ± 11.9 | 0.258 |
DBP (mmHg)3 | 78.8 ± 12.8 | 71.9 ± 7.5 | 0.017* |
Heart rate (beats/minutes)3 | 73.3 ± 12.2 | 77.3 ± 9.3 | 0.052 |
Killip class at admission ≥ II (%)1 | 32.3 | 0 | 0.001** |
Blood glucose (mmol/L)3 | 6.7 ± 2.9 | 5.4 ± 2.0 | 0.720 |
Total cholesterol (mmol/L)3 | 4.7 ± 1.0 | 4.2 ± 1.5 | 0.119 |
Triglycerides (mmol/L)3 | 2.3 ± 3.0 | 1.1 ± 0.6 | 0.002** |
HDL (mmol/L)3 | 1.1 ± 0.3 | 1.2 ± 0.5 | 0.307 |
LDL (mmol/L)3 | 2.7 ± 0.8 | 2.5 ± 1.1 | 0.293 |
WBC (× 109/L)3 | 9.2 ± 3.0 | 7.7 ± 3.2 | 0.067 |
Cr (μmol/L)3 | 63.4 ± 14.0 | 70.0 ± 23.1 | 0.176 |
NT-proBNP (pg/ml)3 | 1497.5 ± 1667.4 | 77.2 ± 86.8 | 0.001** |
CK-MB (U/L)3 | 47.5 ± 72.1 | 12.1 ± 8.9 | < 0.001** |
MYO (μg/L)3 | 55.4 ± 22.8 | 35.4 ± 10.7 | 0.250 |
Hs-cTNT (μg/L)3 | 2.08 ± 2.11 | 0.002 ± 0.000 | < 0.001** |
Concurrent medications | |||
 ACE inhibitors (%)1 | 80.6% | 0 | < 0.001** |
 Beta-blockers (%)1 | 96.8% | 0 | < 0.001** |
 Nitrates (%)1 | 96.8% | 3.7% | < 0.001** |
 Statins (%)1 | 100.0% | 0 | < 0.001** |
 Aspirins (%)1 | 100.0% | 0 | < 0.001** |
 Colpidogrel (%)1 | 41.9% | 0 | < 0.001** |